Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P O Bochkov

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Bulletin of Experimental Biology and Medicine|January 10, 2022
Preclinical Pharmacokinetics of GZK-111, a Dipeptide with Neuroprotective ActivityA A Litvin, G B Kolyvanov, P O Bochkov, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|September 8, 2011
[Pharmacokinetics of afobazole metabolite (M-11) in rats]D V Bastrygin, A O Viglinskaia, G B Kolyvanov, et al.
Bulletin of Experimental Biology and Medicine|October 25, 2018
Metabolism of a Novel Anxiolytic GML-1 in RatsA A Novitskii, P O Bochkov, R V Shevchenko, et al.
Bulletin of Experimental Biology and Medicine|November 1, 2012
Excretion of compound M-11 and its metabolites with urine and feces in ratsD V Bastrygin, A O Viglinskaya, G B Kolyvanov, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|February 22, 2014
[Pharmacokinetic evaluation of a new prolonged dosage form of afobazole in comparison to commercially available tablets]P O Bochkov, A A Litvin, G B Kolyvanov, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|June 4, 2015
[Pharmacokinetic evaluation of afobazole pharmaceutical composition with modified release]P O Bochkov, A A Litvin, G B Kolyvanov, et al.
Bulletin of Experimental Biology and Medicine|March 30, 2022
Metabolism of a New Dipeptide Neuroprotector in RatsG B Kolyvanov, P O Bochkov, A A Litvin, et al.
Bulletin of Experimental Biology and Medicine|October 19, 2019
Comparative Preclinical Pharmacokinetics and Bioavailability of Antidepressant GSB-106 Tablet FormG B Kolyvanov, V P Zherdev, O G Gribakina, et al.
Pharmacogenomics and Personalized Medicine|March 12, 2020
<i>CYP2C19*17</i> May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and RivaroxabanD A Sychev, O A Baturina, K B Mirzaev, et al.
Psychopharmacology Bulletin|December 11, 2023
Relationship of <i>CYP3A4*1B</i> Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic HallucinosisA A Parkhomenko, M S Zastrozhin, VYu Skryabin, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bulletin of Experimental Biology and Medicine|January 10, 2022
Preclinical Pharmacokinetics of GZK-111, a Dipeptide with Neuroprotective ActivityA A Litvin, G B Kolyvanov, P O Bochkov, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|September 8, 2011
[Pharmacokinetics of afobazole metabolite (M-11) in rats]D V Bastrygin, A O Viglinskaia, G B Kolyvanov, et al.
Bulletin of Experimental Biology and Medicine|October 25, 2018
Metabolism of a Novel Anxiolytic GML-1 in RatsA A Novitskii, P O Bochkov, R V Shevchenko, et al.
Bulletin of Experimental Biology and Medicine|November 1, 2012
Excretion of compound M-11 and its metabolites with urine and feces in ratsD V Bastrygin, A O Viglinskaya, G B Kolyvanov, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|February 22, 2014
[Pharmacokinetic evaluation of a new prolonged dosage form of afobazole in comparison to commercially available tablets]P O Bochkov, A A Litvin, G B Kolyvanov, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|June 4, 2015
[Pharmacokinetic evaluation of afobazole pharmaceutical composition with modified release]P O Bochkov, A A Litvin, G B Kolyvanov, et al.
Bulletin of Experimental Biology and Medicine|March 30, 2022
Metabolism of a New Dipeptide Neuroprotector in RatsG B Kolyvanov, P O Bochkov, A A Litvin, et al.
Bulletin of Experimental Biology and Medicine|October 19, 2019
Comparative Preclinical Pharmacokinetics and Bioavailability of Antidepressant GSB-106 Tablet FormG B Kolyvanov, V P Zherdev, O G Gribakina, et al.
Pharmacogenomics and Personalized Medicine|March 12, 2020
<i>CYP2C19*17</i> May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and RivaroxabanD A Sychev, O A Baturina, K B Mirzaev, et al.
Psychopharmacology Bulletin|December 11, 2023
Relationship of <i>CYP3A4*1B</i> Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic HallucinosisA A Parkhomenko, M S Zastrozhin, VYu Skryabin, et al.
Pageof 2